CBSA Remains Active on Critical Federal Legislation

Act Today and Tell Your Member of Congress: Oppose Government Price Setting

Congress is negotiating sweeping legislation that impacts life sciences. The current reconciliation bill includes language that imposes government price setting in Medicare. This could chill investment in next-generation treatments and cures for patients in need and result in significant job losses in the biopharmaceutical sector.

As part of a nationwide effort led by our partners at BIO, CBSA is working to mobilize Colorado’s life sciences community. We support health innovation for patients and oppose government price setting. You must act today and email your members of Congress. Voting on this legislation will take place today and go into the weekend. 

Please take a few minutes to take action and write a letter to your member of Congress using our interactive email tool.

Why It Matters

Price setting will harm patients: Efforts by Congress to impose government price setting in Medicare will result in fewer research and development dollars going toward groundbreaking treatments for patients with life-limiting and fatal conditions.

Price setting will impact jobs in our industry, including here in Colorado: Research indicates the proposed legislation will likely lead to the loss of over 590,000 jobs across the country, dealing a devastating blow to our economy and families everywhere. In Colorado, the legislation could lead to a loss of 1,264 direct biopharma jobs in Colorado and over 6,700 biopharma-supported jobs in our state. That translates to $1,645 million in lost biopharma-supported output.

How CBSA is Engaging with Members of Congress 

CBSA signed onto a letter with BIO and the Council of State Bioscience Associations (CSBA) to Congressional Leadership expressing serious concerns about government price setting in this proposal. CBSA continues collaborating with members and industry partners to voice our concerns and educate lawmakers about how these policies will limit patient access and stifle medical innovation.

How You Can Help

Please email your members of Congress and share this request with your life sciences colleagues.

We urge you to act TODAY!  Now more than ever, we need your voice and engagement to help make the case to delegation members on the devastating impact their support of these policies will have on our community.

Categories: CBSA News